230 Publications (Page 9 of 10)
2008
Hydroxyitraconazole, Formed During Intestinal First-Pass Metabolism of Itraconazole, Controls the Time Course of Hepatic CYP3A Inhibition and the Bioavailability of Itraconazole in Rats. Drug Metabolism and Disposition
. | Journal Article
Interaction between midazolam and clarithromycin in the elderly.Quinney, Sara K⋅Haehner, Barbara D⋅Rhoades, Melissa B⋅Lin, Zhen⋅Gorski, J C and Hall, Stephen DBritish journal of clinical pharmacology, vol. 65, (no. 1), pp. 98-109, 2008/Jan.
| Journal Article
Interaction between midazolam and clarithromycin in the elderly. British Journal of Clinical Pharmacology
. | Journal Article
Onset of inhibitory effect of clarithromycin on human intestinal and hepatic cytochrome P4503A (CYP3A) activity and the influence of CYP3A5 genotype.Malireddy, S.⋅Quinney, S.⋅Hamman, M.⋅Vuppalanchi, R.⋅Pinto, A.⋅Chalasani, N. and Hall, S.(pp. S5)
Onset of inhibitory effect of clarithromycin on human intestinal and hepatic cytochrome P4503A (CYP3A) activity and the influence of CYP3A5 genotype.Malireddy, S.⋅Quinney, S.⋅Hamman, M.⋅Vuppalanchi, R.⋅Pinto, A.⋅Chalasani, N. and Hall, S.Clinical Pharmacology & Therapeutics, vol. 83, pp. S5.
| Journal Article
Onset of inhibitory effect of clarithromycin on human intestinal and hepatic cytochrome P4503A (CYP3A) activity and the influence of CYP3A5 genotype. Clinical Pharmacology & Therapeutics
. | Journal Article
2006
OIV-B-4Physiologically-based pharmacokinetic models for the inhibition of midazolam clearance by erythromycin and diltiazem. Clinical Pharmacology & Therapeutics
. | Journal Article
Physiologically-based pharmacokinetic models for the inhibition of midazolam clearance by erythromycin and diltiazem.Zhang, X⋅Gorski, JC⋅Lucksiri, A⋅Chien, JY⋅Quinney, Sk⋅Jones, DR and Hall, SDClinical Pharmacology & Therapeutics, vol. 79, pp. P34.
| Journal Article
PIII-55Prediction of clarithromycin nonlinear pharmacokinetics and its interaction with midazolam using a physiologically-based pharmacokinetic model. Clinical Pharmacology & Therapeutics
. | Journal Article
Prediction of clarithromycin nonlinear pharmacokinetics and its interaction with midazolam using a physiologically-based pharmacokinetic model.Quinney, Sk⋅Gorski, JC⋅Lucksiri, A⋅Chien, JY⋅Jones, DR and Hall, SDClinical Pharmacology & Therapeutics, vol. 79, pp. P73.
| Journal Article
Time-dependent and organ-dependent metabolism of itraconazole in ratsQuinney, Sara K.⋅Hall, Stephen D.⋅Galinsky, Raymond E.⋅Jiyamapa-Serna, Vanida A.⋅Chen, Yong and Kimura, Robert E.Drug Metabolism Reviews, vol. 38, pp. 130.
| Journal Article
Time-dependent and organ-dependent metabolism of itraconazole in ratsQuinney, Sara K.⋅Hall, Stephen D.⋅Galinsky, Raymond E.⋅Jiyamapa-Serna, Vanida A.⋅Chen, Yong and Kimura, Robert E.(pp. 130)
Time-dependent and organ-dependent metabolism of itraconazole in rats. Drug Metabolism Reviews
. | Journal Article
2005
Hydrolysis of capecitabine to 5 ’-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamideQuinney, S K⋅SK, Quinney⋅Quinney, Sk⋅Sanghani, Sonal P⋅SP, Sanghani⋅Sanghani, SP⋅Davis, WI⋅Davis, W I⋅WI, Davis⋅TD, Hurley⋅Hurley, T D⋅Hurley, TD⋅Sun, Z⋅Z, Sun⋅Sun, Z⋅DJ, Murry⋅Murry, Daryl J⋅Murry, DJ⋅Bosron, WF⋅Bosron, William F and WF, BosronJournal of Pharmacology and Experimental Therapeutics, vol. 313, pp. 1011-1016.
| Journal Article
Hydrolysis of Capecitabine to 5 -Deoxy-5-fluorocytidine by Human Carboxylesterases and Inhibition by Loperamide. Journal of Pharmacology and Experimental Therapeutics
. | Journal Article
2004
Activation of anticancer prodrugs by human carboxylesterases (Dissertation)Quinney, Sara K (2004).
Epirubicin dose escalation in the treatment of soft tissue sarcoma.Rushing, DA⋅Quinney, Sk and Murry, DJJournal of Clinical Oncology, vol. 22, pp. 826S.
| Journal Article
Epirubicin dose escalation in the treatment of soft tissue sarcoma.Rushing, DA⋅Quinney, Sk and Murry, DJ(pp. 826S)
Epirubicin dose escalation in the treatment of soft tissue sarcoma. Journal of Clinical Oncology
. | Journal Article
HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3Sanghani, Sonal⋅Sanghani, Sonal P⋅Quinney, Sara⋅Quinney, Sara K⋅Fredenburg, Tyler B⋅Fredenburg, Tyler⋅Davis, Wilhelmina⋅Davis, Wilhelmina I⋅Murry, Daryl J⋅Murry, Daryl⋅Bosron, William and Bosron, William FDrug Metabolism and Disposition, vol. 32, (no. 5), pp. 511, 20040501.
| Journal Article
HYDROLYSIS OF IRINOTECAN AND ITS OXIDATIVE METABOLITES, 7-ETHYL-10-[4-N-(5-AMINOPENTANOIC ACID)-1-PIPERIDINO] CARBONYLOXYCAMPTOTHECIN AND 7-ETHYL-10-[4-(1-PIPERIDINO)-1-AMINO]-CARBONYLOXYCAMPTOTHECIN, BY HUMAN CARBOXYLESTERASES CES1A1, CES2, AND A NEWLY EXPRESSED CARBOXYLESTERASE ISOENZYME, CES3. Drug Metabolism and Disposition
. | Journal Article
Inhibition of carboxyleseterase activity: Can co-administered agents reduce irinotecan and capecitabine activation?Quinney, Sara K.⋅Murry, Daryl J. and Bosron, William F.Proceedings of the American Association for Cancer Research Annual Meeting, vol. 45, pp. 466.
| Journal Article
Inhibition of carboxyleseterase activity: Can co-administered agents reduce irinotecan and capecitabine activation?Quinney, Sara K.⋅Murry, Daryl J. and Bosron, William F.(pp. 466)
Inhibition of carboxyleseterase activity: Can co-administered agents reduce irinotecan and capecitabine activation? Proceedings of the American Association For Cancer Research (AACR) Annual Meeting
. | Journal Article
2003
Carboxylesterases expressed in human colon tumor tissue and their role in CPT-11 hydrolysisSanghani, SP⋅Quinney, Sk⋅Fredenburg, TB⋅Sun, ZJ⋅Davis, WI⋅Murry, DJ⋅Cummings, OW⋅Seitz, DE and Bosron, WF(pp. 4983-4991)
